- Home
- MYND vs PPCB Comparison
MYND vs PPCB Comparison
Compare MYND & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYND | PPCB |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 18.1M |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | MYND | PPCB |
|---|---|---|
| Price | $0.21 | $1.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 102.5K |
| Earning Date | 08-27-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.00 | $0.06 |
| 52 Week High | $0.66 | $6.79 |
Technical Indicators
Market Signals| Indicator | MYND | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 65.47 |
| Support Level | $0.00 | $1.61 |
| Resistance Level | $0.48 | $1.98 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.52 | 32.19 |
Price Performance
Historical ComparisonAbout MYND Mynd.ai Inc.
Mynd.ai Inc provides world'wide, end-to-end, learning solutions and collaboration tools to help teachers, schools, students, and professionals realize their greatest potential. The company has single reporting segment. The company has presence in United States and Rest of world. The company generates majority of revenue from United States.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.